A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HH2710 in Patient With Advanced Tumors

Clinical trial NCT04198818 · TERMINATED

Trial details

NCT number: NCT04198818
Sponsor: Haihe Biopharma Co., Ltd.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Tumors Melanoma Non-Small-Cell Lung Cancer Erdheim-Chester Disease Other RAS/RAF/MEK/ERK Mutated Tumors

Start date: 2020-01-07
Primary completion: 2023-03-31
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.